Trial Information
Current as of January 14, 2025
Completed
Keywords
ClinConnect Summary
24 adult smokers were recruited through an independent pharmacy in rural Appalachia were randomized to 1 of 8 treatments: (1) pharmacist delivered QuitAid intervention (Yes vs. No), (2) Combination NRT Gum + NRT Patch (vs. NRT patch), and/or (3) 8 weeks of NRT (vs. standard 4 weeks). All participants received 4 weeks of NRT patch in addition to the components to which they were assigned. Participants completed baseline and 3-month follow-up assessments. The primary outcomes were feasibility of recruitment and randomization, retention, treatment adherence and fidelity.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • smokers must have smoked at least 5 cigarettes per day for the past 6 months
- • be willing to set a quit date in the next 30 days
- • own a cell phone
- • be over 18 years of age
- • not be pregnant or planning to become pregnant in the next 6 months
- • not have any medical contraindications to using NRT
- Exclusion Criteria:
- • Those who are pregnant or plan to be
- • Those under 18 years of age
- • Those with a medical contradiction
- • Those who do not own a cell phone
- • Those who have not smoked 5 cigarettes per day for the last 6 months
- • Those who are unwilling to set a quit date within 30 days
Trial Officials
Melissa Little, PhD
Principal Investigator
University of Virginia
About University Of Virginia
The University of Virginia (UVA) is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on interdisciplinary collaboration, UVA leverages its extensive resources and expertise in various fields, including medicine, engineering, and public health, to drive cutting-edge studies that address pressing health challenges. The university's clinical trial programs aim to translate scientific discoveries into effective treatments, ensuring the highest standards of ethical practice and participant safety. Through its strong emphasis on community engagement and education, UVA fosters a culture of research that not only contributes to the scientific community but also enhances the well-being of the populations it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charlottesville, Virginia, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials